(-)-epigallocatechin 3-gallate increases expression EXP 6480464 epigallocatechin gallate results in increased expression of SLC2A1 mRNA CTD PMID:16988119 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:737272 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC2A1 mRNA CTD PMID:22079256 (E)-cinnamyl alcohol multiple interactions ISO RGD:11305 6480464 [cinnamyl alcohol co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein CTD PMID:20955755 (E)-cinnamyl alcohol increases activity ISO RGD:11305 6480464 cinnamyl alcohol results in increased activity of SLC2A1 protein CTD PMID:20955755 (S)-naringenin multiple interactions ISO RGD:737272 6480464 naringenin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] CTD PMID:14642735 (S)-naringenin decreases activity ISO RGD:737272 6480464 naringenin results in decreased activity of SLC2A1 protein CTD PMID:14642735 1,2-dimethylhydrazine decreases expression ISO RGD:11305 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLC2A1 mRNA CTD PMID:22206623 1,4-benzoquinone multiple interactions ISO RGD:737272 6480464 [HIF1A protein co-treated with quinone] results in increased expression of SLC2A1 protein CTD PMID:30448556 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine multiple interactions EXP 6480464 Trimetazidine promotes the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA] CTD PMID:25937560 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:11305 6480464 [Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:25064079 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of SLC2A1 mRNA CTD PMID:17522070 17alpha-ethynylestradiol increases expression ISO RGD:11305 6480464 Ethinyl Estradiol results in increased expression of SLC2A1 mRNA CTD PMID:17555576 , PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of SLC2A1 mRNA CTD PMID:12075121 more ... 17alpha-ethynylestradiol multiple interactions ISO RGD:11305 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC2A1 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:737272 6480464 Estradiol results in increased expression of SLC2A1 mRNA, Estradiol results in increased expression of SLC2A1 protein CTD PMID:14605097 , PMID:15350188 17beta-estradiol multiple interactions ISO RGD:11305 6480464 Estradiol inhibits the reaction [Progesterone results in increased expression of and results in increased localization of SLC2A1 protein], Estradiol inhibits the reaction [Progesterone results in increased expression of SLC2A1 protein] CTD PMID:18948400 17beta-estradiol multiple interactions ISO RGD:737272 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of SLC2A1 protein CTD PMID:15350188 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:11305 6480464 Dihydrotestosterone results in increased expression of SLC2A1 protein CTD PMID:20025956 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:737272 6480464 Dihydrotestosterone results in increased expression of SLC2A1 mRNA CTD PMID:29581250 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:737272 6480464 2 more ... CTD PMID:31251971 2,3',4,4',5-Pentachlorobiphenyl multiple interactions ISO RGD:737272 6480464 Acetylcysteine inhibits the reaction [2 more ... CTD PMID:31251971 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:11305 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC2A1 protein CTD PMID:17872374 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC2A1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737272 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC2A1 mRNA CTD PMID:19684285 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737272 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC2A1 mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC2A1 mRNA CTD PMID:20959002 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11305 6480464 Tetrachlorodibenzodioxin affects the expression of SLC2A1 mRNA CTD PMID:17872374 , PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737272 6480464 Tetrachlorodibenzodioxin affects the expression of SLC2A1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:11305 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC2A1 mRNA CTD PMID:17035482 , PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:11305 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC2A1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737272 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC2A1 mRNA] more ... CTD PMID:19684285 , PMID:23152189 2,3-dinitrophenol increases activity EXP 6480464 2, 3-dinitrophenol results in increased activity of SLC2A1 protein CTD PMID:10970766 2,3-dinitrophenol multiple interactions EXP 6480464 Calcium deficiency inhibits the reaction [2, 3-dinitrophenol results in increased activity of SLC2A1 protein] CTD PMID:10970766 2,6-di-tert-butyl-4-methylphenol increases expression ISO RGD:11305 6480464 Butylated Hydroxytoluene results in increased expression of SLC2A1 mRNA CTD PMID:19000923 2-deoxy-2-((18)F)fluoro-D-glucose multiple interactions ISO RGD:11305 6480464 [MRK 003 results in decreased expression of SLC2A1 protein] which results in decreased uptake of Fluorodeoxyglucose F18 CTD PMID:20197467 2-deoxy-2-((18)F)fluoro-D-glucose affects uptake ISO RGD:737272 6480464 SLC2A1 mRNA affects the uptake of Fluorodeoxyglucose F18 CTD PMID:16595493 2-deoxy-D-glucose increases uptake ISO RGD:737272 6480464 SLC2A1 protein results in increased uptake of Deoxyglucose CTD PMID:2173694 2-deoxy-D-glucose multiple interactions ISO RGD:11305 6480464 [arsenite affects the localization of SLC2A1 protein] which results in increased uptake of Deoxyglucose CTD PMID:14511371 2-deoxy-D-glucose multiple interactions ISO RGD:737272 6480464 [Deoxyglucose results in increased abundance of Glucose] which affects the localization of SLC2A1 protein more ... CTD PMID:2173694 , PMID:31398423 2-methoxy-17beta-estradiol decreases expression EXP 6480464 2-Methoxyestradiol results in decreased expression of SLC2A1 protein CTD PMID:31850806 , PMID:32461003 2-methoxy-17beta-estradiol multiple interactions EXP 6480464 2-Methoxyestradiol promotes the reaction [methylmercuric chloride results in decreased expression of SLC2A1 protein], 2-Methoxyestradiol promotes the reaction [Methylmercury Compounds results in decreased expression of SLC2A1 protein] CTD PMID:31850806 , PMID:32461003 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:737272 6480464 3 more ... CTD PMID:35618242 3,3',5-triiodo-L-thyronine increases expression ISO RGD:737272 6480464 Triiodothyronine results in increased expression of SLC2A1 mRNA CTD PMID:15507505 3,4-dihydroxybenzoic acid increases expression EXP 6480464 protocatechuic acid results in increased expression of SLC2A1 protein CTD PMID:31850806 , PMID:32461003 3,4-dihydroxybenzoic acid multiple interactions EXP 6480464 protocatechuic acid inhibits the reaction [methylmercuric chloride results in decreased expression of SLC2A1 protein], protocatechuic acid inhibits the reaction [Methylmercury Compounds results in decreased expression of SLC2A1 protein] CTD PMID:31850806 , PMID:32461003 3,4-methylenedioxymethamphetamine increases expression ISO RGD:11305 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of SLC2A1 mRNA CTD PMID:20188158 3,5-diethoxycarbonyl-1,4-dihydrocollidine increases expression ISO RGD:11305 6480464 3 more ... CTD PMID:20512997 3-bromopyruvic acid multiple interactions ISO RGD:11305 6480464 [bromopyruvate results in decreased expression of SLC2A1 protein] which results in decreased uptake of Glucose CTD PMID:28433571 3-bromopyruvic acid decreases expression ISO RGD:11305 6480464 bromopyruvate results in decreased expression of SLC2A1 mRNA, bromopyruvate results in decreased expression of SLC2A1 protein CTD PMID:28433571 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of SLC2A1 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:11305 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC2A1 mRNA CTD PMID:31009676 3-methyladenine multiple interactions ISO RGD:737272 6480464 3-methyladenine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A1 protein] more ... CTD PMID:32569804 more ... 3-methyladenine decreases expression ISO RGD:737272 6480464 3-methyladenine results in decreased expression of SLC2A1 protein CTD PMID:36336208 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of SLC2A1 mRNA CTD PMID:21800402 3-O-methyl-D-glucose multiple interactions ISO RGD:737272 6480464 Pentobarbital inhibits the reaction [SLC2A1 protein results in increased uptake of 3-O-Methylglucose] more ... CTD PMID:10590023 3-O-methyl-D-glucose decreases transport ISO RGD:737272 6480464 SLC2A1 protein mutant form results in decreased transport of 3-O-Methylglucose CTD PMID:11603379 3-O-methyl-D-glucose increases uptake ISO RGD:737272 6480464 SLC2A1 protein results in increased uptake of 3-O-Methylglucose CTD PMID:10590023 3-Phenyl-1-propanol multiple interactions ISO RGD:11305 6480464 [3-phenylpropanol-1 co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein CTD PMID:20955755 3-Phenyl-1-propanol increases activity ISO RGD:11305 6480464 3-phenylpropanol-1 results in increased activity of SLC2A1 protein CTD PMID:20955755 3-phenylprop-2-enal increases activity ISO RGD:11305 6480464 cinnamaldehyde results in increased activity of SLC2A1 protein CTD PMID:20955755 3-phenylprop-2-enal multiple interactions ISO RGD:11305 6480464 [cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein more ... CTD PMID:20955755 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of SLC2A1 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol decreases expression ISO RGD:737272 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of SLC2A1 mRNA CTD PMID:27685785 4-hydroxyphenyl retinamide increases expression ISO RGD:11305 6480464 Fenretinide results in increased expression of SLC2A1 mRNA CTD PMID:28973697 4-phenylbutyric acid multiple interactions ISO RGD:737272 6480464 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of SLC2A1 protein] CTD PMID:32569804 , PMID:36473502 5-fluorouracil decreases expression ISO RGD:737272 6480464 Fluorouracil results in decreased expression of SLC2A1 mRNA CTD PMID:16253763 5-fluorouracil decreases activity ISO RGD:737272 6480464 Fluorouracil results in decreased activity of SLC2A1 protein CTD PMID:16253763 5-fluorouracil increases expression ISO RGD:737272 6480464 Fluorouracil results in increased expression of SLC2A1 mRNA CTD PMID:16595493 7-hydroxyflavone multiple interactions ISO RGD:737272 6480464 7-hydroxyflavone inhibits the reaction [SLC2A1 protein affects the transport of Glucose] CTD PMID:14642735 7-hydroxyflavone decreases activity ISO RGD:737272 6480464 7-hydroxyflavone results in decreased activity of SLC2A1 protein CTD PMID:14642735 acadesine increases expression ISO RGD:737272 6480464 acadesine results in increased expression of SLC2A1 mRNA CTD PMID:15864539 acarbose increases expression EXP 6480464 Acarbose results in increased expression of SLC2A1 protein CTD PMID:11779583 acrylamide increases expression ISO RGD:11305 6480464 Acrylamide results in increased expression of SLC2A1 protein CTD PMID:20025956 aflatoxin B1 increases methylation ISO RGD:737272 6480464 Aflatoxin B1 results in increased methylation of SLC2A1 intron CTD PMID:30157460 aflatoxin B1 multiple interactions EXP 6480464 Sildenafil Citrate inhibits the reaction [Aflatoxin B1 results in increased expression of SLC2A1 mRNA], Tadalafil inhibits the reaction [Aflatoxin B1 results in increased expression of SLC2A1 mRNA] CTD PMID:35608386 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SLC2A1 mRNA CTD PMID:35608386 aldehydo-D-glucose multiple interactions ISO RGD:11305 6480464 [2-butenal co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein more ... CTD PMID:18948400 more ... aldehydo-D-glucose increases uptake ISO RGD:737272 6480464 SLC2A1 protein results in increased uptake of Glucose CTD PMID:23615963 aldehydo-D-glucose increases activity ISO RGD:11305 6480464 Glucose deficiency results in increased activity of SLC2A1 protein CTD PMID:19686715 aldehydo-D-glucose increases transport ISO RGD:737272 6480464 SLC2A1 protein results in increased transport of Glucose CTD PMID:18455367 , PMID:8457197 aldehydo-D-glucose increases stability ISO RGD:737272 6480464 Glucose results in increased stability of SLC2A1 protein CTD PMID:11420438 aldehydo-D-glucose increases expression ISO RGD:737272 6480464 Glucose results in increased expression of SLC2A1 mRNA CTD PMID:15864539 aldehydo-D-glucose multiple interactions ISO RGD:737272 6480464 7-hydroxyflavone inhibits the reaction [SLC2A1 protein affects the transport of Glucose] more ... CTD PMID:14642735 more ... aldehydo-D-glucose multiple interactions EXP 6480464 [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose CTD PMID:10726906 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of SLC2A1 mRNA CTD PMID:1727734 all-trans-retinoic acid increases expression ISO RGD:11305 6480464 Tretinoin results in increased expression of SLC2A1 protein CTD PMID:20025956 all-trans-retinoic acid decreases expression ISO RGD:737272 6480464 Tretinoin results in decreased expression of SLC2A1 mRNA CTD PMID:23724009 alpha,alpha-trehalose multiple interactions ISO RGD:11305 6480464 Trehalose inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:25064079 alpha-naphthoflavone multiple interactions ISO RGD:737272 6480464 alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC2A1 mRNA] CTD PMID:23152189 alpha-naphthoflavone increases expression ISO RGD:737272 6480464 alpha-naphthoflavone results in increased expression of SLC2A1 mRNA CTD PMID:23152189 aluminium atom increases expression ISO RGD:737272 6480464 Aluminum results in increased expression of SLC2A1 protein CTD PMID:16979867 aluminium(0) increases expression ISO RGD:737272 6480464 Aluminum results in increased expression of SLC2A1 protein CTD PMID:16979867 amiodarone decreases expression ISO RGD:737272 6480464 Amiodarone results in decreased expression of SLC2A1 mRNA CTD PMID:36586010 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC2A1 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of SLC2A1 mRNA CTD PMID:30779732 anthracene-1,8,9-triol increases expression ISO RGD:11305 6480464 Anthralin results in increased expression of SLC2A1 protein CTD PMID:20025956 antirheumatic drug decreases expression ISO RGD:737272 6480464 Antirheumatic Agents results in decreased expression of SLC2A1 mRNA CTD PMID:24449571 Apaziquone decreases response to substance ISO RGD:737272 6480464 SLC2A1 protein results in decreased susceptibility to apaziquone CTD PMID:17520257 aristolochic acid A decreases expression ISO RGD:737272 6480464 aristolochic acid I results in decreased expression of SLC2A1 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:11305 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC2A1 mRNA CTD PMID:23650126 arsane multiple interactions ISO RGD:737272 6480464 [sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [[Deoxyglucose results in increased abundance of Glucose] which affects the localization of SLC2A1 protein] CTD PMID:31398423 arsenic atom multiple interactions ISO RGD:737272 6480464 [sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [[Deoxyglucose results in increased abundance of Glucose] which affects the localization of SLC2A1 protein] CTD PMID:31398423 arsenite(3-) affects localization ISO RGD:11305 6480464 arsenite affects the localization of SLC2A1 protein CTD PMID:14511371 arsenite(3-) multiple interactions ISO RGD:11305 6480464 [arsenite affects the localization of SLC2A1 protein] which results in increased uptake of Deoxyglucose CTD PMID:14511371 arsenous acid increases import EXP 6480464 SLC2A1 protein results in increased import of Arsenic Trioxide CTD PMID:17064664 arsenous acid multiple interactions ISO RGD:737272 6480464 AKT1 protein affects the reaction [Arsenic Trioxide affects the localization of SLC2A1 protein], BAY-876 inhibits the reaction [Arsenic Trioxide affects the localization of SLC2A1 protein] CTD PMID:35714947 arsenous acid affects localization ISO RGD:737272 6480464 Arsenic Trioxide affects the localization of SLC2A1 protein CTD PMID:35714947 arsenous acid increases import ISO RGD:737272 6480464 SLC2A1 protein results in increased import of Arsenic Trioxide CTD PMID:17064664 arsenous acid increases expression ISO RGD:737272 6480464 Arsenic Trioxide results in increased expression of SLC2A1 mRNA CTD PMID:20458559 , PMID:35714947 ATP decreases stability ISO RGD:737272 6480464 Adenosine Triphosphate results in decreased stability of SLC2A1 protein CTD PMID:11420438 atrazine decreases expression ISO RGD:737272 6480464 Atrazine results in decreased expression of SLC2A1 mRNA CTD PMID:22378314 Azaspiracid increases expression ISO RGD:737272 6480464 azaspiracid results in increased expression of SLC2A1 mRNA CTD PMID:28939011 azide multiple interactions EXP 6480464 Calcium deficiency inhibits the reaction [Azides results in increased activity of SLC2A1 protein] CTD PMID:10970766 azide increases activity EXP 6480464 Azides results in increased activity of SLC2A1 protein CTD PMID:10970766 barbiturates multiple interactions ISO RGD:737272 6480464 Barbiturates inhibits the reaction [SLC2A1 protein results in increased transport of Glucose] CTD PMID:18455367 beauvericin multiple interactions ISO RGD:737272 6480464 [beauvericin co-treated with enniatins] results in increased expression of SLC2A1 protein CTD PMID:32407736 benzaldehyde increases activity ISO RGD:11305 6480464 benzaldehyde results in increased activity of SLC2A1 protein CTD PMID:20955755 benzaldehyde multiple interactions ISO RGD:11305 6480464 [benzaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein CTD PMID:20955755 benzatropine decreases expression ISO RGD:737272 6480464 Benztropine results in decreased expression of SLC2A1 protein CTD PMID:34122009 benzo[a]pyrene affects expression ISO RGD:737272 6480464 Benzo(a)pyrene affects the expression of SLC2A1 mRNA CTD PMID:20106945 benzo[a]pyrene increases expression ISO RGD:737272 6480464 Benzo(a)pyrene results in increased expression of SLC2A1 mRNA CTD PMID:30453624 benzo[a]pyrene affects methylation ISO RGD:737272 6480464 Benzo(a)pyrene affects the methylation of SLC2A1 3' UTR, Benzo(a)pyrene affects the methylation of SLC2A1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:737272 6480464 Benzo(a)pyrene results in decreased expression of SLC2A1 mRNA CTD PMID:21632981 benzo[a]pyrene increases expression ISO RGD:11305 6480464 Benzo(a)pyrene results in increased expression of SLC2A1 mRNA CTD PMID:21569818 more ... benzo[a]pyrene diol epoxide I increases expression ISO RGD:737272 6480464 7 more ... CTD PMID:26238291 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC2A1 protein CTD PMID:28903497 beta-naphthoflavone decreases expression ISO RGD:737272 6480464 beta-Naphthoflavone results in decreased expression of SLC2A1 mRNA CTD PMID:32858204 beta-naphthoflavone decreases expression ISO RGD:11305 6480464 beta-Naphthoflavone results in decreased expression of SLC2A1 mRNA CTD PMID:29521512 bicalutamide multiple interactions EXP 6480464 bicalutamide promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of SLC2A1 protein] CTD PMID:35151640 bicalutamide increases expression EXP 6480464 bicalutamide results in increased expression of SLC2A1 protein CTD PMID:35151640 bicalutamide decreases expression EXP 6480464 bicalutamide results in decreased expression of SLC2A1 protein CTD PMID:35151640 bis(2-ethylhexyl) phthalate increases expression ISO RGD:11305 6480464 Diethylhexyl Phthalate results in increased expression of SLC2A1 mRNA CTD PMID:19000923 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:11305 6480464 Diethylhexyl Phthalate results in decreased expression of SLC2A1 mRNA CTD PMID:29753845 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:737272 6480464 Diethylhexyl Phthalate results in decreased expression of SLC2A1 protein CTD PMID:31163220 bis(2-ethylhexyl) phthalate increases expression ISO RGD:737272 6480464 Diethylhexyl Phthalate results in increased expression of SLC2A1 mRNA CTD PMID:31163220 bisphenol A increases expression ISO RGD:737272 6480464 bisphenol A results in increased expression of SLC2A1 mRNA CTD PMID:24349194 , PMID:25784278 bisphenol A affects expression ISO RGD:737272 6480464 bisphenol A affects the expression of SLC2A1 mRNA CTD PMID:30903817 bisphenol A decreases methylation ISO RGD:11305 6480464 bisphenol A results in decreased methylation of SLC2A1 promoter CTD PMID:27312807 bisphenol A increases methylation ISO RGD:11305 6480464 bisphenol A results in increased methylation of SLC2A1 promoter CTD PMID:27312807 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC2A1 mRNA CTD PMID:12075121 more ... bisphenol A decreases expression ISO RGD:11305 6480464 bisphenol A results in decreased expression of SLC2A1 mRNA, bisphenol A results in decreased expression of SLC2A1 protein CTD PMID:25637671 more ... bisphenol F increases expression ISO RGD:11305 6480464 bisphenol F results in increased expression of SLC2A1 mRNA, bisphenol F results in increased expression of SLC2A1 protein CTD PMID:34147605 bisphenol F multiple interactions ISO RGD:11305 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol F results in increased expression of SLC2A1 mRNA] more ... CTD PMID:34147605 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of SLC2A1 mRNA CTD PMID:32479839 bucladesine multiple interactions ISO RGD:737272 6480464 [Progesterone co-treated with Bucladesine] results in increased expression of SLC2A1 protein CTD PMID:18948400 bupivacaine decreases expression ISO RGD:11305 6480464 Bupivacaine results in decreased expression of SLC2A1 protein CTD PMID:34793778 bupivacaine multiple interactions ISO RGD:11305 6480464 HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of SLC2A1 protein] CTD PMID:34793778 butan-1-ol multiple interactions ISO RGD:11305 6480464 1-Butanol inhibits the reaction [Phospholipids results in increased localization of SLC2A1 protein] CTD PMID:15956784 butylated hydroxyanisole increases expression ISO RGD:11305 6480464 Butylated Hydroxyanisole results in increased expression of SLC2A1 mRNA CTD PMID:19000923 butyric acid multiple interactions ISO RGD:11305 6480464 Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA] CTD PMID:29751049 cadmium atom increases expression ISO RGD:737272 6480464 Cadmium results in increased expression of SLC2A1 mRNA CTD PMID:22562489 cadmium atom multiple interactions ISO RGD:737272 6480464 3-methyladenine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A1 protein] more ... CTD PMID:34481905 , PMID:36336208 cadmium atom multiple interactions ISO RGD:11305 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC2A1 mRNA, [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A1 protein CTD PMID:29373603 , PMID:34481905 cadmium atom multiple interactions EXP 6480464 [cadmium acetate results in increased abundance of Cadmium] which results in decreased expression of SLC2A1 protein, puerarin inhibits the reaction [[cadmium acetate results in increased abundance of Cadmium] which results in decreased expression of SLC2A1 protein] CTD PMID:33404196 cadmium dichloride decreases expression ISO RGD:737272 6480464 Cadmium Chloride results in decreased expression of SLC2A1 mRNA CTD PMID:12760830 cadmium dichloride multiple interactions ISO RGD:737272 6480464 3-methyladenine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A1 protein] more ... CTD PMID:34481905 , PMID:36336208 cadmium dichloride increases expression ISO RGD:11305 6480464 Cadmium Chloride results in increased expression of SLC2A1 mRNA CTD PMID:30615929 cadmium dichloride increases expression ISO RGD:737272 6480464 Cadmium Chloride results in increased expression of SLC2A1 mRNA CTD PMID:12160620 , PMID:25596134 cadmium dichloride multiple interactions ISO RGD:11305 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC2A1 mRNA more ... CTD PMID:23880315 more ... cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SLC2A1 mRNA CTD PMID:19010381 caffeine increases expression ISO RGD:737272 6480464 Caffeine results in increased expression of SLC2A1 protein CTD PMID:25486098 caffeine decreases phosphorylation ISO RGD:737272 6480464 Caffeine results in decreased phosphorylation of SLC2A1 protein CTD PMID:35688186 calcium atom multiple interactions EXP 6480464 Calcium deficiency inhibits the reaction [2 more ... CTD PMID:10970766 calcium(0) multiple interactions EXP 6480464 Calcium deficiency inhibits the reaction [2 more ... CTD PMID:10970766 cannabidiol decreases expression ISO RGD:737272 6480464 Cannabidiol results in decreased expression of SLC2A1 protein CTD PMID:34122009 carbon nanotube increases expression ISO RGD:11305 6480464 Nanotubes more ... CTD PMID:25554681 CCCP multiple interactions ISO RGD:737272 6480464 Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A1 protein] CTD PMID:34481905 celecoxib multiple interactions ISO RGD:11305 6480464 Celecoxib inhibits the reaction [Nickel results in increased expression of SLC2A1 mRNA] CTD PMID:27452194 celecoxib increases expression ISO RGD:737272 6480464 Celecoxib results in increased expression of SLC2A1 mRNA CTD PMID:19327236 chloral hydrate multiple interactions ISO RGD:737272 6480464 Chloral Hydrate inhibits the reaction [SLC2A1 protein results in increased transport of Glucose] CTD PMID:18455367 chloroacetaldehyde increases expression ISO RGD:737272 6480464 chloroacetaldehyde results in increased expression of SLC2A1 mRNA CTD PMID:25596134 chloroform increases expression EXP 6480464 Chloroform results in increased expression of SLC2A1 mRNA CTD PMID:17522070 chloropicrin affects expression ISO RGD:737272 6480464 chloropicrin affects the expression of SLC2A1 mRNA CTD PMID:26352163 chloropicrin decreases expression ISO RGD:737272 6480464 chloropicrin results in decreased expression of SLC2A1 mRNA CTD PMID:28476498 chloroprene increases expression ISO RGD:11305 6480464 Chloroprene results in increased expression of SLC2A1 mRNA CTD PMID:23125180 cholic acid increases expression ISO RGD:11305 6480464 Cholic Acid results in increased expression of SLC2A1 protein CTD PMID:20025956 chromium atom multiple interactions EXP 6480464 Chromium inhibits the reaction [Dietary Fats results in decreased expression of SLC2A1 protein] CTD PMID:21120707 chromium(6+) affects expression ISO RGD:11305 6480464 chromium hexavalent ion affects the expression of SLC2A1 mRNA CTD PMID:28472532 chromium(6+) increases expression ISO RGD:737272 6480464 chromium hexavalent ion results in increased expression of SLC2A1 mRNA CTD PMID:30690063 cidofovir anhydrous increases expression ISO RGD:737272 6480464 Cidofovir results in increased expression of SLC2A1 mRNA CTD PMID:25596134 cinnamyl alcohol multiple interactions ISO RGD:11305 6480464 [cinnamyl alcohol co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein CTD PMID:20955755 cinnamyl alcohol increases activity ISO RGD:11305 6480464 cinnamyl alcohol results in increased activity of SLC2A1 protein CTD PMID:20955755 ciprofloxacin affects localization ISO RGD:737272 6480464 Ciprofloxacin affects the localization of SLC2A1 mRNA CTD PMID:19022360 ciprofloxacin decreases expression ISO RGD:737272 6480464 Ciprofloxacin results in decreased expression of SLC2A1 mRNA CTD PMID:19022360 cisplatin increases phosphorylation ISO RGD:11305 6480464 Cisplatin results in increased phosphorylation of SLC2A1 protein CTD PMID:22006019 cisplatin decreases expression ISO RGD:737272 6480464 Cisplatin results in decreased expression of SLC2A1 mRNA CTD PMID:29690507 cisplatin multiple interactions ISO RGD:737272 6480464 [Cisplatin co-treated with eprenetapopt] promotes the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA] more ... CTD PMID:27392435 , PMID:29690507 cisplatin increases expression ISO RGD:737272 6480464 Cisplatin results in increased expression of SLC2A1 mRNA CTD PMID:25596134 clobetasol increases expression ISO RGD:11305 6480464 Clobetasol results in increased expression of SLC2A1 mRNA CTD PMID:27462272 clofibrate increases expression ISO RGD:11305 6480464 Clofibrate results in increased expression of SLC2A1 protein CTD PMID:20025956 cobalt dichloride multiple interactions ISO RGD:737272 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of SLC2A1 protein] more ... CTD PMID:17442736 more ... cobalt dichloride increases expression ISO RGD:737272 6480464 cobaltous chloride results in increased expression of SLC2A1 mRNA, cobaltous chloride results in increased expression of SLC2A1 protein CTD PMID:12032628 more ... cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of SLC2A1 mRNA, cobaltous chloride results in increased expression of SLC2A1 protein CTD PMID:12819242 more ... cobalt dichloride increases expression ISO RGD:11305 6480464 cobaltous chloride results in increased expression of SLC2A1 mRNA CTD PMID:11043581 , PMID:24265542 cobalt dichloride multiple interactions EXP 6480464 [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of SLC2A1 mRNA more ... CTD PMID:18331222 more ... cobalt dichloride multiple interactions ISO RGD:11305 6480464 ARNT affects the reaction [cobaltous chloride results in increased expression of SLC2A1 mRNA] CTD PMID:11043581 copper atom multiple interactions ISO RGD:737272 6480464 [Chelating Agents binds to Copper] which results in increased expression of SLC2A1 mRNA more ... CTD PMID:20971185 more ... copper(0) multiple interactions ISO RGD:737272 6480464 [Chelating Agents binds to Copper] which results in increased expression of SLC2A1 mRNA more ... CTD PMID:20971185 more ... copper(II) chloride increases expression ISO RGD:737272 6480464 cupric chloride results in increased expression of SLC2A1 mRNA CTD PMID:15741220 copper(II) sulfate affects expression ISO RGD:737272 6480464 Copper Sulfate affects the expression of SLC2A1 mRNA CTD PMID:19549813 corosolic acid multiple interactions ISO RGD:11305 6480464 corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of SLC2A1 mRNA] CTD PMID:34296331 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of SLC2A1 mRNA CTD PMID:15755911 corticosterone multiple interactions ISO RGD:11305 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA more ... CTD PMID:29751049 crotonaldehyde increases activity ISO RGD:11305 6480464 2-butenal results in increased activity of SLC2A1 protein CTD PMID:20955755 crotonaldehyde multiple interactions ISO RGD:11305 6480464 [2-butenal co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein CTD PMID:20955755 cumene multiple interactions ISO RGD:11305 6480464 [cumene co-treated with KRAS gene mutant form] results in decreased expression of SLC2A1 mRNA CTD PMID:18648096 curcumin decreases expression ISO RGD:11305 6480464 Curcumin results in decreased expression of SLC2A1 mRNA CTD PMID:21397623 Cyclofenil multiple interactions ISO RGD:737272 6480464 Cyclofenil inhibits the reaction [SLC2A1 protein affects the transport of Glucose] CTD PMID:14642735 Cyclofenil decreases activity ISO RGD:737272 6480464 Cyclofenil results in decreased activity of SLC2A1 protein CTD PMID:14642735 cycloheximide multiple interactions ISO RGD:737272 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of SLC2A1 mRNA CTD PMID:19684285 cyclosporin A increases expression ISO RGD:11305 6480464 Cyclosporine results in increased expression of SLC2A1 mRNA CTD PMID:19770486 cyclosporin A increases expression ISO RGD:737272 6480464 Cyclosporine results in increased expression of SLC2A1 mRNA CTD PMID:25596134 cyclosporin A decreases expression ISO RGD:737272 6480464 Cyclosporine results in decreased expression of SLC2A1 mRNA CTD PMID:25562108 cytarabine decreases expression ISO RGD:737272 6480464 Cytarabine results in decreased expression of SLC2A1 mRNA CTD PMID:21198554 cytochalasin B multiple interactions ISO RGD:11305 6480464 oxophenylarsine inhibits the reaction [Cytochalasin B binds to SLC2A1 protein] CTD PMID:19686715 cytochalasin B affects binding ISO RGD:11305 6480464 Cytochalasin B binds to SLC2A1 protein CTD PMID:19686715 cytochalasin B multiple interactions ISO RGD:737272 6480464 Cytochalasin B inhibits the reaction [SLC2A1 protein results in increased transport of Glucose] CTD PMID:8457197 cytochalasin B affects folding ISO RGD:737272 6480464 Cytochalasin B affects the folding of SLC2A1 protein CTD PMID:22363641 D-glucose multiple interactions ISO RGD:737272 6480464 7-hydroxyflavone inhibits the reaction [SLC2A1 protein affects the transport of Glucose] more ... CTD PMID:14642735 more ... D-glucose increases uptake ISO RGD:737272 6480464 SLC2A1 protein results in increased uptake of Glucose CTD PMID:23615963 D-glucose multiple interactions EXP 6480464 [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose CTD PMID:10726906 D-glucose increases expression ISO RGD:737272 6480464 Glucose results in increased expression of SLC2A1 mRNA CTD PMID:15864539 D-glucose increases activity ISO RGD:11305 6480464 Glucose deficiency results in increased activity of SLC2A1 protein CTD PMID:19686715 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of SLC2A1 mRNA CTD PMID:1727734 D-glucose multiple interactions ISO RGD:11305 6480464 [2-butenal co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein more ... CTD PMID:18948400 more ... D-glucose increases transport ISO RGD:737272 6480464 SLC2A1 protein results in increased transport of Glucose CTD PMID:18455367 , PMID:8457197 D-glucose increases stability ISO RGD:737272 6480464 Glucose results in increased stability of SLC2A1 protein CTD PMID:11420438 dacarbazine decreases response to substance ISO RGD:737272 6480464 SLC2A1 protein results in decreased susceptibility to Dacarbazine CTD PMID:17520257 daidzein decreases activity ISO RGD:737272 6480464 daidzein results in decreased activity of SLC2A1 protein CTD PMID:14642735 daidzein multiple interactions ISO RGD:737272 6480464 daidzein inhibits the reaction [SLC2A1 protein affects the transport of Glucose] CTD PMID:14642735 DDT multiple interactions ISO RGD:737272 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [DDT results in increased expression of SLC2A1 mRNA] more ... CTD PMID:31724279 DDT increases expression ISO RGD:737272 6480464 DDT results in increased expression of SLC2A1 mRNA CTD PMID:31724279 deguelin increases expression ISO RGD:737272 6480464 deguelin results in increased expression of SLC2A1 mRNA CTD PMID:33512557 dehydroascorbic acid decreases transport ISO RGD:737272 6480464 SLC2A1 protein mutant form results in decreased transport of Dehydroascorbic Acid CTD PMID:11603379 dehydroascorbic acid affects transport EXP 6480464 SLC2A1 protein affects the transport of Dehydroascorbic Acid CTD PMID:15590689 dehydroascorbic acid affects uptake ISO RGD:737272 6480464 SLC2A1 mRNA affects the uptake of Dehydroascorbic Acid CTD PMID:16142743 Deoxycorticosterone acetate multiple interactions EXP 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride co-treated with cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester] results in increased expression of SLC2A1 protein CTD PMID:29621749 desferrioxamine B multiple interactions ISO RGD:737272 6480464 [Deferoxamine results in decreased abundance of Oxygen] which results in increased expression of SLC2A1 protein more ... CTD PMID:17442736 , PMID:36116563 desferrioxamine B increases expression ISO RGD:737272 6480464 Deferoxamine results in increased expression of SLC2A1 mRNA CTD PMID:12032628 , PMID:21558026 dexamethasone multiple interactions ISO RGD:11305 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC2A1 mRNA, Dexamethasone inhibits the reaction [Nickel results in increased expression of SLC2A1 mRNA] CTD PMID:27452194 , PMID:31009676 dextran sulfate increases expression ISO RGD:11305 6480464 Dextran Sulfate results in increased expression of SLC2A1 protein CTD PMID:20025956 diarsenic trioxide increases expression ISO RGD:737272 6480464 Arsenic Trioxide results in increased expression of SLC2A1 mRNA CTD PMID:20458559 , PMID:35714947 diarsenic trioxide multiple interactions ISO RGD:737272 6480464 AKT1 protein affects the reaction [Arsenic Trioxide affects the localization of SLC2A1 protein], BAY-876 inhibits the reaction [Arsenic Trioxide affects the localization of SLC2A1 protein] CTD PMID:35714947 diarsenic trioxide affects localization ISO RGD:737272 6480464 Arsenic Trioxide affects the localization of SLC2A1 protein CTD PMID:35714947 diarsenic trioxide increases import ISO RGD:737272 6480464 SLC2A1 protein results in increased import of Arsenic Trioxide CTD PMID:17064664 diarsenic trioxide increases import EXP 6480464 SLC2A1 protein results in increased import of Arsenic Trioxide CTD PMID:17064664 diazepam multiple interactions ISO RGD:737272 6480464 Diazepam inhibits the reaction [SLC2A1 protein results in increased transport of Glucose] CTD PMID:18455367 dibenz[a,h]anthracene increases expression ISO RGD:737272 6480464 1 more ... CTD PMID:16269432 dichloroacetic acid decreases expression ISO RGD:11305 6480464 Dichloroacetic Acid results in decreased expression of SLC2A1 mRNA, Dichloroacetic Acid results in decreased expression of SLC2A1 protein CTD PMID:22705712 dicrotophos increases expression ISO RGD:737272 6480464 dicrotophos results in increased expression of SLC2A1 mRNA CTD PMID:28302478 diethylstilbestrol decreases activity ISO RGD:737272 6480464 Diethylstilbestrol results in decreased activity of SLC2A1 protein CTD PMID:14642735 diethylstilbestrol multiple interactions ISO RGD:737272 6480464 Diethylstilbestrol inhibits the reaction [SLC2A1 protein affects the transport of Glucose] CTD PMID:14642735 Dihydrotanshinone I multiple interactions ISO RGD:737272 6480464 dihydrotanshinone I inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 protein] CTD PMID:26282490 dinophysistoxin 1 increases expression ISO RGD:737272 6480464 dinophysistoxin 1 results in increased expression of SLC2A1 mRNA CTD PMID:28939011 dioxygen multiple interactions ISO RGD:737272 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 protein] more ... CTD PMID:10780954 more ... dioxygen increases expression ISO RGD:737272 6480464 Oxygen deficiency results in increased expression of SLC2A1 mRNA, Oxygen deficiency results in increased expression of SLC2A1 protein CTD PMID:10780954 more ... dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of SLC2A1 mRNA, Oxygen deficiency results in increased expression of SLC2A1 protein CTD PMID:11524615 more ... dioxygen decreases expression ISO RGD:11305 6480464 Oxygen results in decreased expression of SLC2A1 mRNA CTD PMID:23034257 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of SLC2A1 mRNA more ... CTD PMID:18331222 more ... dioxygen multiple interactions ISO RGD:11305 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC2A1 mRNA more ... CTD PMID:20412331 more ... dioxygen increases expression ISO RGD:11305 6480464 Oxygen deficiency results in increased expression of SLC2A1 mRNA CTD PMID:20412331 more ... dioxygen decreases response to substance ISO RGD:737272 6480464 SLC2A1 protein results in decreased susceptibility to Oxygen deficiency CTD PMID:10780954 dorsomorphin multiple interactions ISO RGD:737272 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:737272 6480464 Doxorubicin results in increased expression of SLC2A1 mRNA CTD PMID:16595493 , PMID:29803840 doxorubicin decreases expression ISO RGD:11305 6480464 Doxorubicin results in decreased expression of SLC2A1 mRNA CTD PMID:34296331 doxorubicin decreases expression ISO RGD:737272 6480464 Doxorubicin results in decreased expression of SLC2A1 mRNA CTD PMID:22908232 doxorubicin multiple interactions ISO RGD:11305 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of SLC2A1 mRNA, corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of SLC2A1 mRNA] CTD PMID:21040762 , PMID:34296331 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SLC2A1 mRNA CTD PMID:29391264 enniatin multiple interactions ISO RGD:737272 6480464 [beauvericin co-treated with enniatins] results in increased expression of SLC2A1 protein CTD PMID:32407736 epoxiconazole decreases expression ISO RGD:11305 6480464 epoxiconazole results in decreased expression of SLC2A1 mRNA CTD PMID:35436446 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of SLC2A1 mRNA CTD PMID:17920746 ethanol multiple interactions ISO RGD:737272 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of SLC2A1 mRNA CTD PMID:23378141 ethanol increases expression ISO RGD:11305 6480464 Ethanol results in increased expression of SLC2A1 mRNA CTD PMID:19167417 , PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:737272 6480464 Ethyl Methanesulfonate results in decreased expression of SLC2A1 mRNA CTD PMID:23649840 fenbendazole decreases expression ISO RGD:737272 6480464 Fenbendazole analog results in decreased expression of SLC2A1 mRNA, Fenbendazole results in decreased expression of SLC2A1 mRNA CTD PMID:35569513 fenthion decreases expression ISO RGD:11305 6480464 Fenthion results in decreased expression of SLC2A1 mRNA CTD PMID:34813904 folic acid multiple interactions ISO RGD:737272 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of SLC2A1 mRNA CTD PMID:23378141 formaldehyde multiple interactions ISO RGD:737272 6480464 Deferoxamine inhibits the reaction [myricetin inhibits the reaction [Formaldehyde results in increased expression of SLC2A1 mRNA]] more ... CTD PMID:36116563 formaldehyde increases expression ISO RGD:737272 6480464 Formaldehyde results in increased expression of SLC2A1 mRNA, Formaldehyde results in increased expression of SLC2A1 protein CTD PMID:36116563 fulvestrant multiple interactions ISO RGD:11305 6480464 Fulvestrant inhibits the reaction [bisphenol F results in increased expression of SLC2A1 protein] CTD PMID:34147605 Fusaric acid affects expression ISO RGD:11305 6480464 Fusaric Acid affects the expression of SLC2A1 mRNA CTD PMID:32156565 Genipin multiple interactions ISO RGD:737272 6480464 genipin inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA] CTD PMID:29630948 genistein multiple interactions ISO RGD:737272 6480464 Genistein inhibits the reaction [SLC2A1 protein affects the transport of Glucose] CTD PMID:14642735 genistein increases expression EXP 6480464 Genistein results in increased expression of SLC2A1 mRNA CTD PMID:12075121 genistein decreases activity ISO RGD:737272 6480464 Genistein results in decreased activity of SLC2A1 protein CTD PMID:14642735 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC2A1 mRNA CTD PMID:33387578 gentamycin C increases expression ISO RGD:11305 6480464 gentamicin C results in increased expression of SLC2A1 mRNA CTD PMID:12927799 glucose multiple interactions ISO RGD:737272 6480464 7-hydroxyflavone inhibits the reaction [SLC2A1 protein affects the transport of Glucose] more ... CTD PMID:14642735 more ... glucose increases uptake ISO RGD:737272 6480464 SLC2A1 protein results in increased uptake of Glucose CTD PMID:23615963 glucose multiple interactions EXP 6480464 [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose CTD PMID:10726906 glucose increases expression ISO RGD:737272 6480464 Glucose results in increased expression of SLC2A1 mRNA CTD PMID:15864539 glucose increases activity ISO RGD:11305 6480464 Glucose deficiency results in increased activity of SLC2A1 protein CTD PMID:19686715 glucose decreases expression EXP 6480464 Glucose results in decreased expression of SLC2A1 mRNA CTD PMID:1727734 glucose multiple interactions ISO RGD:11305 6480464 [2-butenal co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein more ... CTD PMID:18948400 more ... glucose increases transport ISO RGD:737272 6480464 SLC2A1 protein results in increased transport of Glucose CTD PMID:18455367 , PMID:8457197 glucose increases stability ISO RGD:737272 6480464 Glucose results in increased stability of SLC2A1 protein CTD PMID:11420438 glycine decreases expression ISO RGD:737272 6480464 Glycine results in decreased expression of SLC2A1 protein CTD PMID:30605748 glyphosate increases expression ISO RGD:737272 6480464 glyphosate results in increased expression of SLC2A1 protein CTD PMID:30605748 hexadecanoic acid multiple interactions ISO RGD:737272 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of SLC2A1 mRNA CTD PMID:30547786 hydrazine increases expression EXP 6480464 hydrazine results in increased expression of SLC2A1 mRNA CTD PMID:15370871 hydrogen peroxide affects expression ISO RGD:737272 6480464 Hydrogen Peroxide affects the expression of SLC2A1 mRNA CTD PMID:20044591 hydrogen peroxide decreases expression ISO RGD:737272 6480464 Hydrogen Peroxide results in decreased expression of SLC2A1 protein CTD PMID:21179406 hydrogen sulfide decreases expression ISO RGD:11305 6480464 Hydrogen Sulfide results in decreased expression of SLC2A1 protein CTD PMID:29932956 hydroquinone increases expression EXP 6480464 hydroquinone results in increased expression of SLC2A1 protein CTD PMID:27587462 ibuprofen decreases expression ISO RGD:737272 6480464 Ibuprofen results in decreased expression of SLC2A1 protein CTD PMID:12912967 ibuprofen increases expression ISO RGD:737272 6480464 Ibuprofen results in increased expression of SLC2A1 mRNA CTD PMID:25596134 ifosfamide increases expression ISO RGD:737272 6480464 Ifosfamide results in increased expression of SLC2A1 mRNA CTD PMID:25596134 indometacin multiple interactions ISO RGD:11305 6480464 Indomethacin inhibits the reaction [Nickel results in increased expression of SLC2A1 mRNA] CTD PMID:27452194 iron dichloride increases expression ISO RGD:11305 6480464 ferrous chloride results in increased expression of SLC2A1 protein CTD PMID:20025956 isoliquiritigenin multiple interactions ISO RGD:737272 6480464 isoliquiritigenin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] CTD PMID:14642735 isoliquiritigenin decreases activity ISO RGD:737272 6480464 isoliquiritigenin results in decreased activity of SLC2A1 protein CTD PMID:14642735 isoprenaline increases expression ISO RGD:11305 6480464 Isoproterenol results in increased expression of SLC2A1 mRNA CTD PMID:20003209 ivermectin decreases expression ISO RGD:11305 6480464 Ivermectin results in decreased expression of SLC2A1 mRNA CTD PMID:28942281 ivermectin decreases expression ISO RGD:737272 6480464 Ivermectin results in decreased expression of SLC2A1 protein CTD PMID:32959892 kaempferide decreases expression ISO RGD:737272 6480464 kaempferide results in decreased expression of SLC2A1 mRNA CTD PMID:21865046 kaempferol decreases activity ISO RGD:737272 6480464 kaempferol results in decreased activity of SLC2A1 protein CTD PMID:14642735 kaempferol decreases expression ISO RGD:737272 6480464 kaempferol results in decreased expression of SLC2A1 mRNA CTD PMID:25719685 kaempferol multiple interactions ISO RGD:737272 6480464 kaempferol inhibits the reaction [SLC2A1 protein affects the transport of Glucose] CTD PMID:14642735 L-ascorbic acid increases expression EXP 6480464 Ascorbic Acid results in increased expression of SLC2A1 mRNA CTD PMID:15372504 L-cysteine multiple interactions ISO RGD:11305 6480464 Cysteine inhibits the reaction [[cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein] CTD PMID:20955755 L-dehydroascorbic acid decreases transport ISO RGD:737272 6480464 SLC2A1 protein mutant form results in decreased transport of Dehydroascorbic Acid CTD PMID:11603379 L-dehydroascorbic acid affects transport EXP 6480464 SLC2A1 protein affects the transport of Dehydroascorbic Acid CTD PMID:15590689 L-dehydroascorbic acid affects uptake ISO RGD:737272 6480464 SLC2A1 mRNA affects the uptake of Dehydroascorbic Acid CTD PMID:16142743 L-mimosine increases expression ISO RGD:737272 6480464 Mimosine results in increased expression of SLC2A1 mRNA CTD PMID:25469848 L-mimosine increases expression EXP 6480464 Mimosine results in increased expression of SLC2A1 mRNA CTD PMID:25469848 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of SLC2A1 mRNA, lead acetate results in increased expression of SLC2A1 protein CTD PMID:30980912 lead diacetate multiple interactions ISO RGD:11305 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein, [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein] CTD PMID:34508822 lead diacetate multiple interactions ISO RGD:737272 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 mRNA more ... CTD PMID:31874198 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of SLC2A1 protein CTD PMID:22129743 lead(0) multiple interactions ISO RGD:11305 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein, [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein] CTD PMID:34508822 lead(0) multiple interactions ISO RGD:737272 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 mRNA more ... CTD PMID:31874198 lead(0) multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Lead results in decreased expression of SLC2A1 protein] CTD PMID:22129743 lead(2+) decreases expression EXP 6480464 Lead results in decreased expression of SLC2A1 protein CTD PMID:22129743 lead(2+) multiple interactions ISO RGD:11305 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein, [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein] CTD PMID:34508822 lead(2+) multiple interactions ISO RGD:737272 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 mRNA more ... CTD PMID:31874198 lead(2+) multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Lead results in decreased expression of SLC2A1 protein] CTD PMID:22129743 leflunomide increases expression ISO RGD:737272 6480464 leflunomide results in increased expression of SLC2A1 mRNA CTD PMID:28988120 lipopolysaccharide affects expression EXP 6480464 Lipopolysaccharides affects the expression of SLC2A1 protein CTD PMID:16902764 lipopolysaccharide multiple interactions EXP 6480464 [Valproic Acid co-treated with Lipopolysaccharides] results in decreased expression of SLC2A1 protein, Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of SLC2A1 mRNA] CTD PMID:16415329 , PMID:16902764 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of SLC2A1 mRNA CTD PMID:16415329 lithocholic acid increases expression ISO RGD:11305 6480464 Lithocholic Acid results in increased expression of SLC2A1 mRNA CTD PMID:19000923 LY294002 multiple interactions ISO RGD:737272 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of SLC2A1 protein] more ... CTD PMID:19808899 , PMID:35122754 LY294002 decreases expression ISO RGD:737272 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of SLC2A1 protein CTD PMID:35122754 LY294002 multiple interactions ISO RGD:11305 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol F results in increased expression of SLC2A1 mRNA] more ... CTD PMID:15956784 , PMID:34147605 menadione affects expression ISO RGD:737272 6480464 Vitamin K 3 affects the expression of SLC2A1 mRNA CTD PMID:20044591 menadione decreases expression ISO RGD:11305 6480464 Vitamin K 3 results in decreased expression of SLC2A1 mRNA CTD PMID:25270620 mercaptoethanol multiple interactions ISO RGD:11305 6480464 Mercaptoethanol inhibits the reaction [[cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein] CTD PMID:20955755 methapyrilene multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Methapyrilene] results in increased expression of SLC2A1 protein CTD PMID:28903497 methapyrilene affects expression EXP 6480464 Methapyrilene affects the expression of SLC2A1 mRNA CTD PMID:28903497 methyl methanesulfonate decreases expression ISO RGD:737272 6480464 Methyl Methanesulfonate results in decreased expression of SLC2A1 mRNA CTD PMID:23649840 methylarsonic acid increases import ISO RGD:737272 6480464 SLC2A1 protein results in increased import of monomethylarsonic acid CTD PMID:17064664 methylarsonic acid increases import EXP 6480464 SLC2A1 protein results in increased import of monomethylarsonic acid CTD PMID:17064664 methylene blue multiple interactions ISO RGD:11305 6480464 oxophenylarsine inhibits the reaction [Methylene Blue results in increased activity of SLC2A1 protein] CTD PMID:19686715 methylene blue increases activity ISO RGD:11305 6480464 Methylene Blue results in increased activity of SLC2A1 protein CTD PMID:19686715 methylmercury chloride increases expression ISO RGD:11305 6480464 methylmercuric chloride results in increased expression of SLC2A1 protein CTD PMID:15649634 methylmercury chloride multiple interactions EXP 6480464 2-Methoxyestradiol promotes the reaction [methylmercuric chloride results in decreased expression of SLC2A1 protein] more ... CTD PMID:31850806 methylmercury chloride decreases expression ISO RGD:737272 6480464 methylmercuric chloride results in decreased expression of SLC2A1 mRNA CTD PMID:23179753 , PMID:27188386 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of SLC2A1 protein CTD PMID:31850806 Mezerein increases expression ISO RGD:11305 6480464 mezerein results in increased expression of SLC2A1 mRNA CTD PMID:19000923 mifepristone multiple interactions ISO RGD:11305 6480464 Mifepristone inhibits the reaction [Progesterone results in increased expression of SLC2A1 protein] CTD PMID:18948400 minocycline multiple interactions ISO RGD:737272 6480464 Minocycline inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA] CTD PMID:24292262 mono(2-ethylhexyl) phthalate increases expression ISO RGD:11305 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of SLC2A1 mRNA CTD PMID:31009676 monosodium L-glutamate multiple interactions ISO RGD:11305 6480464 [Rosiglitazone co-treated with Sodium Glutamate] results in decreased expression of SLC2A1 mRNA, [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of SLC2A1 mRNA CTD PMID:18048028 , PMID:19001666 myricetin multiple interactions ISO RGD:737272 6480464 Deferoxamine inhibits the reaction [myricetin inhibits the reaction [Formaldehyde results in increased expression of SLC2A1 mRNA]] more ... CTD PMID:14642735 , PMID:36116563 myricetin decreases activity ISO RGD:737272 6480464 myricetin results in decreased activity of SLC2A1 protein CTD PMID:14642735 N-acetyl-L-cysteine multiple interactions ISO RGD:737272 6480464 Acetylcysteine inhibits the reaction [2 more ... CTD PMID:31251971 , PMID:31724279 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:737272 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SLC2A1 protein CTD PMID:17442736 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [methylmercuric chloride results in decreased expression of SLC2A1 protein], benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Methylmercury Compounds results in decreased expression of SLC2A1 protein] CTD PMID:31850806 , PMID:32461003 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SLC2A1 protein CTD PMID:31850806 , PMID:32461003 N-methyl-4-phenylpyridinium decreases expression ISO RGD:11305 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SLC2A1 mRNA CTD PMID:17475336 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:11305 6480464 1-Methyl-4-phenylpyridinium promotes the reaction [IL4 protein results in increased expression of SLC2A1 mRNA], IL4 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SLC2A1 mRNA] CTD PMID:32606391 N-methyl-4-phenylpyridinium increases expression ISO RGD:11305 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC2A1 mRNA CTD PMID:30686998 , PMID:32606391 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC2A1 protein more ... CTD PMID:28903497 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of SLC2A1 protein CTD PMID:7921415 , PMID:8364915 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of SLC2A1 mRNA] CTD PMID:16415329 nickel atom increases expression ISO RGD:737272 6480464 Nickel results in increased expression of SLC2A1 mRNA CTD PMID:24768652 , PMID:25583101 nickel atom increases expression ISO RGD:11305 6480464 Nickel results in increased expression of SLC2A1 mRNA CTD PMID:27452194 nickel atom multiple interactions ISO RGD:11305 6480464 Celecoxib inhibits the reaction [Nickel results in increased expression of SLC2A1 mRNA] more ... CTD PMID:27452194 nickel dichloride increases expression EXP 6480464 nickel chloride results in increased expression of SLC2A1 mRNA CTD PMID:22110744 nickel dichloride increases expression ISO RGD:11305 6480464 nickel chloride results in increased expression of SLC2A1 mRNA CTD PMID:12426141 more ... nickel dichloride multiple interactions ISO RGD:11305 6480464 Dinoprostone promotes the reaction [nickel chloride results in increased expression of SLC2A1 mRNA], HIF1A affects the reaction [nickel chloride results in increased expression of SLC2A1 mRNA] CTD PMID:12426141 more ... nickel dichloride increases expression ISO RGD:737272 6480464 nickel chloride results in increased expression of SLC2A1 mRNA CTD PMID:33596451 nickel dichloride multiple interactions ISO RGD:737272 6480464 2-amino-3-(4'-N, N-bis(2-chloroethyl)amino)phenylpropionic acid N-oxide inhibits the reaction [nickel chloride results in increased expression of SLC2A1 mRNA] CTD PMID:33596451 nickel subsulfide affects expression ISO RGD:11305 6480464 nickel subsulfide affects the expression of SLC2A1 mRNA CTD PMID:12729255 nickel sulfate increases expression ISO RGD:11305 6480464 nickel sulfate results in increased expression of SLC2A1 mRNA CTD PMID:16100012 niclosamide decreases expression ISO RGD:737272 6480464 Niclosamide results in decreased expression of SLC2A1 mRNA CTD PMID:22576131 Niflumic acid multiple interactions ISO RGD:11305 6480464 SLC2A1 inhibits the reaction [Niflumic Acid results in increased uptake of Hexoses] CTD PMID:16447059 nimesulide multiple interactions ISO RGD:11305 6480464 SLC2A1 inhibits the reaction [nimesulide results in increased uptake of Hexoses] CTD PMID:16447059 Nonidet P-40 increases expression ISO RGD:737272 6480464 Nonidet P-40 results in increased expression of SLC2A1 mRNA CTD PMID:26552463 ochratoxin A increases expression ISO RGD:737272 6480464 ochratoxin A results in increased expression of SLC2A1 mRNA, ochratoxin A results in increased expression of SLC2A1 protein CTD PMID:32835834 ofloxacin affects localization ISO RGD:737272 6480464 Ofloxacin affects the localization of SLC2A1 mRNA CTD PMID:19022360 ofloxacin decreases expression ISO RGD:737272 6480464 Ofloxacin results in decreased expression of SLC2A1 mRNA CTD PMID:19022360 okadaic acid increases expression ISO RGD:11305 6480464 Okadaic Acid results in increased expression of SLC2A1 mRNA CTD PMID:19000923 okadaic acid increases expression ISO RGD:737272 6480464 Okadaic Acid results in increased expression of SLC2A1 mRNA CTD PMID:28939011 oleic acid multiple interactions ISO RGD:737272 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of SLC2A1 mRNA CTD PMID:30547786 organoselenium compound multiple interactions ISO RGD:737272 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of SLC2A1 mRNA CTD PMID:25167922 ozone increases expression ISO RGD:737272 6480464 Ozone results in increased expression of SLC2A1 mRNA CTD PMID:27206323 p-chloromercuribenzoic acid decreases expression ISO RGD:737272 6480464 p-Chloromercuribenzoic Acid results in decreased expression of SLC2A1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:737272 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC2A1 mRNA CTD PMID:27188386 palytoxin increases expression ISO RGD:11305 6480464 palytoxin results in increased expression of SLC2A1 protein CTD PMID:20025956 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC2A1 mRNA CTD PMID:17522070 , PMID:33387578 paracetamol affects expression ISO RGD:11305 6480464 Acetaminophen affects the expression of SLC2A1 mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of SLC2A1 mRNA CTD PMID:18198484 , PMID:32680482 paraquat increases expression ISO RGD:11305 6480464 Paraquat results in increased expression of SLC2A1 mRNA CTD PMID:21463325 pentachlorophenol increases expression ISO RGD:11305 6480464 Pentachlorophenol results in increased expression of SLC2A1 mRNA CTD PMID:23892564 pentobarbital multiple interactions ISO RGD:737272 6480464 Pentobarbital inhibits the reaction [SLC2A1 protein results in increased uptake of 3-O-Methylglucose], Pentobarbital promotes the reaction [SLC2A1 gene polymorphism results in decreased uptake of 3-O-Methylglucose] CTD PMID:10590023 pentobarbital decreases activity ISO RGD:737272 6480464 Pentobarbital results in decreased activity of SLC2A1 protein CTD PMID:10590023 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:737272 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC2A1 mRNA CTD PMID:32790152 perfluorooctanoic acid decreases expression ISO RGD:737272 6480464 perfluorooctanoic acid results in decreased expression of SLC2A1 mRNA CTD PMID:32790152 , PMID:36326898 permethrin multiple interactions ISO RGD:11305 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA more ... CTD PMID:29751049 phenobarbital multiple interactions ISO RGD:737272 6480464 Phenobarbital inhibits the reaction [SLC2A1 protein results in increased uptake of 3-O-Methylglucose], Phenobarbital promotes the reaction [SLC2A1 gene polymorphism results in decreased uptake of 3-O-Methylglucose] CTD PMID:10590023 phenobarbital affects expression ISO RGD:11305 6480464 Phenobarbital affects the expression of SLC2A1 mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:11305 6480464 Phenobarbital results in increased expression of SLC2A1 mRNA CTD PMID:19000923 phenobarbital affects expression ISO RGD:737272 6480464 Phenobarbital affects the expression of SLC2A1 mRNA CTD PMID:19159669 phenobarbital decreases activity ISO RGD:737272 6480464 Phenobarbital results in decreased activity of SLC2A1 protein CTD PMID:10590023 phenylarsine oxide multiple interactions ISO RGD:11305 6480464 oxophenylarsine inhibits the reaction [Cytochalasin B binds to SLC2A1 protein] more ... CTD PMID:19686715 phenylarsine oxide affects activity ISO RGD:11305 6480464 oxophenylarsine affects the activity of SLC2A1 protein CTD PMID:19686715 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of SLC2A1 mRNA CTD PMID:15808844 phenylmercury acetate increases expression ISO RGD:737272 6480464 Phenylmercuric Acetate results in increased expression of SLC2A1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:737272 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A1 mRNA CTD PMID:27188386 phloretin multiple interactions ISO RGD:737272 6480464 Phloretin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] CTD PMID:14642735 phloretin decreases activity ISO RGD:737272 6480464 Phloretin results in decreased activity of SLC2A1 protein CTD PMID:14642735 phorbol 13-acetate 12-myristate increases expression ISO RGD:11305 6480464 Tetradecanoylphorbol Acetate results in increased expression of SLC2A1 mRNA CTD PMID:19000923 piperonyl butoxide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of SLC2A1 protein CTD PMID:28903497 pirinixic acid decreases expression ISO RGD:11305 6480464 pirinixic acid results in decreased expression of SLC2A1 mRNA CTD PMID:17426115 potassium chromate increases expression ISO RGD:737272 6480464 potassium chromate(VI) results in increased expression of SLC2A1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:737272 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC2A1 mRNA CTD PMID:22079256 potassium dichromate multiple interactions ISO RGD:737272 6480464 3-methyladenine inhibits the reaction [Potassium Dichromate results in increased expression of SLC2A1 protein] more ... CTD PMID:32569804 , PMID:36473502 potassium dichromate increases expression ISO RGD:737272 6480464 Potassium Dichromate results in increased expression of SLC2A1 protein CTD PMID:32569804 , PMID:36473502 probenecid multiple interactions ISO RGD:11305 6480464 [Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:25064079 prochloraz decreases expression ISO RGD:737272 6480464 prochloraz results in decreased expression of SLC2A1 mRNA CTD PMID:30879083 progesterone increases expression ISO RGD:737272 6480464 Progesterone results in increased expression of SLC2A1 protein CTD PMID:15350188 progesterone increases expression ISO RGD:11305 6480464 Progesterone results in increased expression of SLC2A1 mRNA CTD PMID:18948400 progesterone multiple interactions ISO RGD:11305 6480464 [Progesterone results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose more ... CTD PMID:18948400 progesterone increases expression EXP 6480464 Progesterone results in increased expression of SLC2A1 mRNA CTD PMID:20726854 progesterone multiple interactions EXP 6480464 Progesterone promotes the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA] CTD PMID:23307114 progesterone multiple interactions ISO RGD:737272 6480464 [Progesterone co-treated with Bucladesine] results in increased expression of SLC2A1 protein, [Progesterone co-treated with Estradiol] results in decreased expression of SLC2A1 protein CTD PMID:15350188 , PMID:18948400 promethazine decreases expression EXP 6480464 Promethazine results in decreased expression of SLC2A1 mRNA CTD PMID:28903497 propanal multiple interactions ISO RGD:11305 6480464 [propionaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein CTD PMID:20955755 propanal increases activity ISO RGD:11305 6480464 propionaldehyde results in increased activity of SLC2A1 protein CTD PMID:20955755 propofol decreases expression ISO RGD:737272 6480464 Propofol results in decreased expression of SLC2A1 protein CTD PMID:36207479 prostaglandin E2 multiple interactions ISO RGD:11305 6480464 Dinoprostone promotes the reaction [nickel chloride results in increased expression of SLC2A1 mRNA] CTD PMID:27452194 prostaglandin E2 increases expression ISO RGD:11305 6480464 Dinoprostone results in increased expression of SLC2A1 mRNA CTD PMID:27452194 protoporphyrin decreases expression ISO RGD:737272 6480464 protoporphyrin IX results in decreased expression of SLC2A1 mRNA CTD PMID:23624237 puerarin multiple interactions EXP 6480464 puerarin inhibits the reaction [[cadmium acetate results in increased abundance of Cadmium] which results in decreased expression of SLC2A1 protein] CTD PMID:33404196 Pyridostigmine bromide multiple interactions ISO RGD:11305 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA more ... CTD PMID:29751049 pyrithiamine decreases expression EXP 6480464 Pyrithiamine results in decreased expression of SLC2A1 protein CTD PMID:27984051 quercetin multiple interactions ISO RGD:737272 6480464 Quercetin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] CTD PMID:14642735 quercetin affects localization ISO RGD:737272 6480464 Quercetin affects the localization of SLC2A1 protein CTD PMID:26943884 quercetin decreases expression ISO RGD:737272 6480464 Quercetin results in decreased expression of SLC2A1 mRNA CTD PMID:20596804 quercetin decreases activity ISO RGD:737272 6480464 Quercetin results in decreased activity of SLC2A1 protein CTD PMID:14642735 ranitidine multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of SLC2A1 mRNA] CTD PMID:16415329 resveratrol decreases expression ISO RGD:11305 6480464 resveratrol results in decreased expression of SLC2A1 protein CTD PMID:24221993 resveratrol affects binding ISO RGD:737272 6480464 resveratrol binds to SLC2A1 protein CTD PMID:23615963 resveratrol multiple interactions ISO RGD:737272 6480464 [resveratrol binds to SLC2A1 protein] which results in decreased transport of Hexoses, resveratrol inhibits the reaction [SLC2A1 protein results in increased uptake of Glucose] CTD PMID:23615963 rofecoxib multiple interactions ISO RGD:11305 6480464 SLC2A1 inhibits the reaction [rofecoxib results in increased uptake of Hexoses] CTD PMID:16447059 rotenone multiple interactions ISO RGD:737272 6480464 Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA], SLC2A1 protein inhibits the reaction [Rotenone results in increased activity of MAPK8 protein] CTD PMID:10780954 , PMID:19091749 rotenone decreases expression ISO RGD:737272 6480464 Rotenone results in decreased expression of SLC2A1 mRNA CTD PMID:36586010 rotenone increases expression ISO RGD:11305 6480464 Rotenone results in increased expression of SLC2A1 mRNA CTD PMID:30686998 rotenone decreases response to substance ISO RGD:737272 6480464 SLC2A1 protein results in decreased susceptibility to Rotenone CTD PMID:10780954 roxadustat increases expression ISO RGD:737272 6480464 roxadustat results in increased expression of SLC2A1 mRNA CTD PMID:33596451 saccharin increases expression ISO RGD:11305 6480464 Saccharin results in increased expression of SLC2A1 mRNA CTD PMID:19000923 sarpogrelate affects expression EXP 6480464 sarpogrelate affects the expression of SLC2A1 protein CTD PMID:21183729 SB 431542 multiple interactions ISO RGD:737272 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos increases expression ISO RGD:737272 6480464 Asbestos, Serpentine results in increased expression of SLC2A1 mRNA CTD PMID:29523930 sevoflurane increases expression ISO RGD:737272 6480464 Sevoflurane results in increased expression of SLC2A1 protein CTD PMID:36207479 sevoflurane decreases expression ISO RGD:11305 6480464 Sevoflurane results in decreased expression of SLC2A1 protein CTD PMID:35249202 sildenafil citrate multiple interactions EXP 6480464 Sildenafil Citrate inhibits the reaction [Aflatoxin B1 results in increased expression of SLC2A1 mRNA] CTD PMID:35608386 sirolimus multiple interactions ISO RGD:737272 6480464 Sirolimus inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A1 protein], Sirolimus inhibits the reaction [ATG4B protein results in increased expression of SLC2A1 protein] CTD PMID:36336208 sodium arsenite decreases expression ISO RGD:737272 6480464 sodium arsenite results in decreased expression of SLC2A1 mRNA CTD PMID:12760830 , PMID:36586010 sodium arsenite multiple interactions ISO RGD:737272 6480464 [sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [[Deoxyglucose results in increased abundance of Glucose] which affects the localization of SLC2A1 protein] CTD PMID:31398423 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of SLC2A1 protein CTD PMID:29459688 sodium arsenite decreases expression ISO RGD:11305 6480464 sodium arsenite results in decreased expression of SLC2A1 mRNA, sodium arsenite results in decreased expression of SLC2A1 protein CTD PMID:25576766 more ... sodium arsenite increases expression ISO RGD:737272 6480464 sodium arsenite results in increased expression of SLC2A1 mRNA CTD PMID:20886546 sodium azide increases expression ISO RGD:11305 6480464 Sodium Azide results in increased expression of SLC2A1 mRNA CTD PMID:14578187 sodium chloride increases expression ISO RGD:11305 6480464 Sodium Chloride results in increased expression of SLC2A1 protein CTD PMID:20025956 sodium chloride multiple interactions EXP 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride co-treated with cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester] results in increased expression of SLC2A1 protein CTD PMID:29621749 sodium dichromate decreases expression ISO RGD:737272 6480464 sodium bichromate results in decreased expression of SLC2A1 mRNA CTD PMID:12760830 streptozocin multiple interactions EXP 6480464 [Streptozocin co-treated with Dietary Fats] results in decreased expression of SLC2A1 protein more ... CTD PMID:16409969 , PMID:35151640 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of SLC2A1 mRNA CTD PMID:16409969 sulfadimethoxine increases expression ISO RGD:11305 6480464 Sulfadimethoxine results in increased expression of SLC2A1 mRNA CTD PMID:19000923 sunitinib increases expression ISO RGD:737272 6480464 Sunitinib results in increased expression of SLC2A1 mRNA CTD PMID:31533062 tadalafil multiple interactions EXP 6480464 Tadalafil inhibits the reaction [Aflatoxin B1 results in increased expression of SLC2A1 mRNA] CTD PMID:35608386 tamoxifen multiple interactions ISO RGD:737272 6480464 Tamoxifen inhibits the reaction [SLC2A1 protein affects the transport of Glucose] CTD PMID:14642735 tamoxifen affects expression ISO RGD:11305 6480464 Tamoxifen affects the expression of SLC2A1 mRNA CTD PMID:17555576 tamoxifen decreases activity ISO RGD:737272 6480464 Tamoxifen results in decreased activity of SLC2A1 protein CTD PMID:14642735 temozolomide increases expression ISO RGD:737272 6480464 Temozolomide results in increased expression of SLC2A1 mRNA CTD PMID:31758290 tetrachloromethane affects expression ISO RGD:11305 6480464 Carbon Tetrachloride affects the expression of SLC2A1 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:11305 6480464 Carbon Tetrachloride results in increased expression of SLC2A1 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SLC2A1 mRNA CTD PMID:17522070 tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of SLC2A1 mRNA CTD PMID:17522070 tetraethylenepentamine multiple interactions ISO RGD:737272 6480464 tetraethylenepentamine inhibits the reaction [cobaltous chloride results in increased expression of SLC2A1 mRNA] CTD PMID:25100165 thimerosal decreases expression ISO RGD:737272 6480464 Thimerosal results in decreased expression of SLC2A1 mRNA CTD PMID:27188386 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC2A1 mRNA CTD PMID:28903497 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC2A1 mRNA CTD PMID:34492290 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of SLC2A1 protein CTD PMID:28903497 tin(II) chloride (anhydrous) increases expression ISO RGD:11305 6480464 stannous chloride results in increased expression of SLC2A1 mRNA CTD PMID:19000923 tolbutamide increases expression ISO RGD:11305 6480464 Tolbutamide results in increased expression of SLC2A1 mRNA, Tolbutamide results in increased expression of SLC2A1 protein CTD PMID:11835228 , PMID:2682625 tolfenamic acid multiple interactions ISO RGD:737272 6480464 tolfenamic acid affects the reaction [TGFB1 protein affects the expression of SLC2A1 protein] CTD PMID:31381904 toluene increases expression EXP 6480464 Toluene results in increased expression of SLC2A1 mRNA CTD PMID:22967744 Tributyltin oxide increases expression ISO RGD:11305 6480464 bis(tri-n-butyltin)oxide results in increased expression of SLC2A1 mRNA CTD PMID:25270620 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC2A1 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:737272 6480464 trichostatin A results in increased expression of SLC2A1 mRNA CTD PMID:24935251 triclosan increases expression ISO RGD:737272 6480464 Triclosan results in increased expression of SLC2A1 mRNA CTD PMID:30510588 Triptolide decreases expression ISO RGD:11305 6480464 triptolide results in decreased expression of SLC2A1 mRNA, triptolide results in decreased expression of SLC2A1 protein CTD PMID:31618665 , PMID:34087332 Triptolide increases expression ISO RGD:11305 6480464 triptolide results in increased expression of SLC2A1 mRNA CTD PMID:34087332 Triptolide multiple interactions ISO RGD:11305 6480464 TRP53 protein affects the reaction [triptolide results in decreased expression of SLC2A1 protein] CTD PMID:31618665 Triptolide multiple interactions EXP 6480464 pifithrin inhibits the reaction [triptolide results in decreased expression of SLC2A1 protein] CTD PMID:31618665 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of SLC2A1 protein CTD PMID:31618665 triptonide decreases expression ISO RGD:11305 6480464 triptonide results in decreased expression of SLC2A1 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:737272 6480464 tris(2-butoxyethyl) phosphate affects the expression of SLC2A1 mRNA CTD PMID:29024780 troglitazone increases expression ISO RGD:737272 6480464 troglitazone results in increased expression of SLC2A1 mRNA, troglitazone results in increased expression of SLC2A1 protein CTD PMID:9544743 , PMID:9589670 troglitazone decreases expression ISO RGD:737272 6480464 troglitazone results in decreased expression of SLC2A1 mRNA CTD PMID:11162573 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of SLC2A1 mRNA CTD PMID:10726906 troglitazone multiple interactions EXP 6480464 [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose CTD PMID:10726906 troglitazone increases expression ISO RGD:11305 6480464 troglitazone results in increased expression of SLC2A1 mRNA, troglitazone results in increased expression of SLC2A1 protein CTD PMID:28973697 , PMID:8895337 troglitazone multiple interactions ISO RGD:11305 6480464 [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose, [troglitazone results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose CTD PMID:8895337 tunicamycin decreases expression ISO RGD:11305 6480464 Tunicamycin results in decreased expression of SLC2A1 mRNA CTD PMID:24370435 tunicamycin increases expression ISO RGD:737272 6480464 Tunicamycin results in increased expression of SLC2A1 protein CTD PMID:36473502 tunicamycin decreases expression ISO RGD:737272 6480464 Tunicamycin results in decreased expression of SLC2A1 mRNA CTD PMID:22378314 valproic acid multiple interactions ISO RGD:737272 6480464 Valproic Acid inhibits the reaction [SLC2A1 protein results in increased transport of Glucose] CTD PMID:18455367 valproic acid decreases expression ISO RGD:737272 6480464 Valproic Acid results in decreased expression of SLC2A1 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid increases expression ISO RGD:737272 6480464 Valproic Acid results in increased expression of SLC2A1 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions EXP 6480464 [Valproic Acid co-treated with Lipopolysaccharides] results in decreased expression of SLC2A1 protein CTD PMID:16902764 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of SLC2A1 protein CTD PMID:16902764 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SLC2A1 mRNA CTD PMID:23034163 vincristine decreases response to substance ISO RGD:737272 6480464 SLC2A1 protein results in decreased susceptibility to Vincristine CTD PMID:17520257 vorinostat decreases expression ISO RGD:737272 6480464 vorinostat results in decreased expression of SLC2A1 mRNA CTD PMID:27188386 Yessotoxin increases expression ISO RGD:737272 6480464 yessotoxin analog results in increased expression of SLC2A1 mRNA CTD PMID:30679557 zidovudine decreases expression ISO RGD:737272 6480464 Zidovudine results in decreased expression of SLC2A1 mRNA CTD PMID:24292225 zinc acetate multiple interactions ISO RGD:11305 6480464 [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein] CTD PMID:34508822 zinc atom multiple interactions ISO RGD:11305 6480464 [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein] CTD PMID:34508822 zinc dichloride multiple interactions ISO RGD:737272 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SLC2A1 mRNA] CTD PMID:22202117 zinc dichloride increases expression ISO RGD:11305 6480464 zinc chloride results in increased expression of SLC2A1 mRNA CTD PMID:19000923 zinc(0) multiple interactions ISO RGD:11305 6480464 [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein] CTD PMID:34508822
